XML 105 R41.htm IDEA: XBRL DOCUMENT

Note 16 - Stock-Based Compensation (Tables)

12 Months Ended

36 Months Ended

Dec. 31, 2012

Dec. 31, 2012

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

						Weighted				Weighted
						Average				Average				Aggregate
		Number of				Exercise				Remaining				Intrinsic
		Options Shares				Price				Contract Life				Value

Outstanding Options, January 1, 2012			273,201,350			$	0.1872
Granted			27,847,050			$	0.1013
Exercised			(1,566,650	)		$	0.0509
Forfeited or expired			(38,160,300	)		$	0.2520

Outstanding Options, December 31, 2012			261,321,450			$	0.1694				3.36			$	431,000

Vested and Expected to Vest Options at December 31, 2012			252,452,250			$	0.1713				3.24			$	431,000

Exercisable Options at December 31, 2012			222,227,400			$	0.1789				2.81			$	415,000

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

			Options Outstanding												Options Exercisable
							Weighted
							Average				Weighted								Weighted
							Remaining				Average				Number				Average
			Number				Contractual				Exercise				Exercisable				Exercise
Range of Exercise Prices			Outstanding				Life				Price				and Vested				Price

$0.0460	-	$0.0948		53,430,950				5.08			$	0.0652				38,752,500			$	0.0563
$0.1000	-	$0.1538		48,960,500				4.79			$	0.1290				31,064,800			$	0.1349
$0.1594	-	$0.1922		46,058,100				2.57			$	0.1666				39,538,200			$	0.1671
$0.2036	-	$0.2072		64,488,300				2.96			$	0.2038				64,488,300			$	0.2038
$0.2116	-	$0.4792		48,383,600				1.28			$	0.2822				48,383,600			$	0.2822

Balance, December 31, 2012				261,321,450				3.36			$	0.1694				222,227,400			$	0.1789

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

						Weighted
		Number of				Average
		Outstanding				Grant-Date
		Awards				Fair Value

Nonvested at January 1, 2012			33,965,200			$	0.1066
Granted			20,089,850			$	0.1013
Vested			(15,245,000	)		$	0.0967
Forfeited and expired			(5,971,500	)		$	0.1172

Nonvested at December 31, 2012			32,838,550			$	0.1061

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

		Stock Options												Employee Stock Purchase Plan
		Years Ended December 31												Years Ended December 31
		2012				2011				2010				2012				2011				2010

Risk-free interest rate		0.59%	-	1.04%		0.83%	-	2.24%		1.17%	-	2.55%		0.06%	-	0.10%		0.01%	-	0.15%		0.10%	-	0.17%
Expected life (Years)				5				5				5		0.25	-	0.26		0.25	-	0.26		0.25	-	0.26
Volatility		48%	-	50%		50%	-	52%		52%	-	54%		27%	-	45%		34%	-	42%		39%	-	52%
Dividend		-				-				-				-				-				-

Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]

Outstanding stock options			261,321,450
Outstanding RSUs			32,838,550
Shares reserved for future stock option grants			71,162,300
Shares reserved for Employee Stock Purchase Plan			21,665,950
Shares reserved for Awards			95,756,450
			482,744,700

Tabular disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used. Disclosure may also include a description of the accounting policies followed for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt the latest guidance and new ESOP shares for which the new guidance is required, the accounting policies for both blocks of shares may be described. Disclosure may also include he amount of compensation cost recognized during the period, the number of allocated shares, committed-to-be-released shares, and suspense shares held by the ESOP at the balance-sheet date, the fair value of unearned ESOP shares at the balance-sheet date for shares accounted for under the latest guidance, the existence and nature of any repurchase obligation, including disclosure of the fair value of the shares allocated as of the balance sheet date, which are subject to a repurchase obligation.

+ References+ Details

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References+ Details